Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Alzheimer's: Page 2
Quest Diagnostics launches consumer-initiated Alzheimer’s risk assessment test
By
LabPulse.com staff writers
The new test uses the same technology as Quest's clinical AD-Detect Amyloid Beta 42/40 Ratio biomarker test for assessing amyloid beta protein, a recognized marker for Alzheimer’s, which was made available for physicians in early 2022.
August 1, 2023
Cumulus Neuroscience partners with U.K. universities on cognition test for early Alzheimer’s diagnosis
By
Matt Limb
The partnership will look to scale the development and testing of the Fastball EEG test, which uses an EEG headset to measure brain activity while patients watch a series of flashing images displayed on a tablet or smartphone screen.
July 25, 2023
DiamiR Biosciences partners with JADBio on diagnostic tests, validation for biomarker panels
By
Matt Limb
Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform.
July 12, 2023
Roche receives FDA clearance for test to accelerate diagnosis of Alzheimer’s
By
Nick Paul Taylor
The new 510(k) clearance covers two tests that run on Roche’s Elecsys immunoassay system. One of the assays, which measures beta-amyloid, was part of the 510(k) clearance that Roche received last year.
June 29, 2023
Biotech firm AltPep closes $53M Series B financing round
By
LabPulse.com staff writers
AltPep said that the proceeds from the round will be used to accelerate its Sobin therapeutics for Alzheimer’s and Parkinson’s diseases into phase I clinical trials, as well as to advance its Soba diagnostic blood-based assay for Alzheimer’s disease.
June 23, 2023
Alzheimer’s and encephalopathy linked to eye biomarkers
By
Elissa Wolfson
Study finds Alzheimer's disease and chronic traumatic encephalopathy cases are linked to biomarkers present in the eye’s vitreous humor.
June 20, 2023
Gut bacteria changes in preclinical Alzheimer’s suggest ways to detect, delay disease
By
Nick Paul Taylor
Earlier studies found that the gut microbiomes of people with symptomatic Alzheimer’s differ from those of healthy people of the same age, but were unable to tell how early the divergence begins.
June 14, 2023
Blood biomarker in study predicts whether the cognitively healthy will develop Alzheimer’s
By
LabPulse.com staff writers
Astrocytes -- a subtype of glial cells that make up most cells in the human central nervous system -- may be the key driver of Alzheimer's disease progression, researchers said.
May 30, 2023
Alzheimer’s disease and modifiable risk factors: Genetic associations revealed
By
Elissa Wolfson
Novel genetic associations between increased Alzheimer’s disease risk and high HDL cholesterol and high systolic blood pressure were revealed in a study.
May 17, 2023
Quest Diagnostics extends Alzheimer's disease portfolio with AI-enabled test service
By
LabPulse.com staff writers
The RestoreU Dementia Panel employs artificial intelligence developed by uMethod to create personalized care plans aimed at helping physicians improve patient care while also satisfying cognitive care guidelines.
May 4, 2023
C2N Diagnostics announces study confirming accuracy of test for Alzheimer’s diagnosis
By
LabPulse.com staff writers
The study results show that the amyloid probability score (APS) as measured by the PrecivityAD test accurately reflects the amyloid pathology characteristic of progressive Alzheimer’s disease.
March 30, 2023
Study takes aim at blood test for multiple pathways implicated in Alzheimer's disease
By
Elissa Wolfson
The study may ultimately lead to more personalized patient care through the development of a blood test for multiple pathways implicated in the disease, the researchers said.
March 29, 2023
Previous Page
Page 2 of 8
Next Page